Clinical Trials Logo

Clinical Trial Summary

A trial to investigate the safety and efficacy of SVF for the treatment of knee arthrosis. Patients will undergo a single liposuction to obtain the SVF. The SVF will then be isolated and frozen in our laboratory. The SVF will then be injected up to 2 times into the fat pad of the patient's knee.


Clinical Trial Description

Stromal Vascular Fraction (SVF) from adipose tissue is increasingly being used in the clinic for a variety of conditions (skin disorders, joint pain, etc.). SVF is a collective term for cells that can be obtained from liposuction fat. These cells can be separated from the fat by mechanical processing of the liposuction fat combined with an additional centrifugation. Despite the fact that enough SVF can be isolated after such a liposuction for multiple treatments (>3), our research group has found a way to safely freeze SVF without significant loss of SVF cells. In this way, a patient would only have to undergo one liposuction and associated anesthesia to be able to obtain multiple SVF treatments. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06171204
Study type Interventional
Source University Hospital, Ghent
Contact Bernard Depypere, MD
Phone 093325730
Email bernard.depypere@ugent.be
Status Recruiting
Phase N/A
Start date September 19, 2022
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Completed NCT01206634 - Regenerative Injection Therapy and Osteoarthritis Phase 4
Not yet recruiting NCT04001699 - Interprofessional Preoperative Geriatric Assessment for Older Arthroplasty Patients With Multimorbidity N/A